Chromos Molecular Systems is Biotechnology in Canada that focus on developer business. Founded in 1995. They cover business area such as developer, artificial chromosome technology, use, biopharmaceutical production, proprietary arti?cial chromosome expression system technology, production quality cell line, monoclonal antibody, human therapeutic product.
1995
( 29 years old in 2024 )
Developer
-
2020 1055 West Hastings Street
Vancouver, British Columbia
Canada
Private
developerartificial chromosome technologyusebiopharmaceutical productionproprietary arti?cial chromosome expression system technologyproduction quality cell linemonoclonal antibodyhuman therapeutic product
* We use standard office opening hours in near Chromos Molecular Systems's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Chromos Molecular Systems is Biotechnology business from Canada that founded in 1995 (29 years old in 2024), Chromos Molecular Systems business is focusing on Developer.
Chromos Molecular Systems headquarter office and corporate office address is located in 2020 1055 West Hastings Street Vancouver, British Columbia Canada.
Chromos Molecular Systems was founded in Canada.
In 2024, Chromos Molecular Systems is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Chromos Molecular Systems, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
